Results of simulation of performance indicators for the oncological service when introducing innovative technologies for treatment of stage IV lung cancer
Malignant tumors of the trachea, bronchi, lungs represent a serious medical and social problem. Most cases of cancer of the trachea, bronchus, and lung are detected at stage IV, and therefore, to improve the survival of patients, a new treatment strategy is proposed based on modern data on mutagenes...
Saved in:
| Main Authors: | S. A. Sterlikov, O. V. Zelenova, S. I. Аbramov, V. M. Danilov, Yu. V. Mikhaylova, N. A. Golubev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
New Terra Publishing House
2020-05-01
|
| Series: | Туберкулез и болезни лёгких |
| Subjects: | |
| Online Access: | https://www.tibl-journal.com/jour/article/view/1413 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stage IV lung cancer: Is cure possible?
by: Ravi Thippeswamy, et al.
Published: (2013-01-01) -
Modern treatment approaches for patients with IV stage of non-small cell lung cancer
by: А. V. Kadzhoian
Published: (2013-06-01) -
Substantiation of Expressive Markers Use to Personalize Lung Cancer Chemotherapy
by: M. M. Tsyganov, et al.
Published: (2020-05-01) -
EFFECT OF CHEMOTHERAPY WITH DOCETAXEL / CISPLATIN ON GRANULOCYTIC HEMOPOIESIS IN PATIENTS WITH NON-SMALL CELL LUNG CARCINOMA
by: V. E. Goldberg, et al.
Published: (2016-11-01) -
Impact of Treatment Duration in First-Line Atezolizumab Plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer: A Multicenter Real-World Retrospective Study
by: Mehmet Nuri Baser, et al.
Published: (2025-07-01)